CENTRE LEON BERARD

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

First Posted Date
2018-06-27
Last Posted Date
2024-08-26
Lead Sponsor
Centre Leon Berard
Target Recruit Count
90
Registration Number
NCT03571633
Locations
🇫🇷

Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France

🇫🇷

Centre Leon Berard, Lyon, France

🇫🇷

CHRU Besançon, Besançon, France

and more 6 locations

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer

First Posted Date
2018-05-18
Last Posted Date
2023-03-22
Lead Sponsor
Centre Leon Berard
Target Recruit Count
436
Registration Number
NCT03529383
Locations
🇫🇷

CHRU Besançon, Besançon, France

🇫🇷

Institut Sainte-Catherine, Avignon, France

🇫🇷

Centre Léon Bérard, Lyon, France

The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC)

Active, not recruiting
Conditions
Interventions
First Posted Date
2018-03-21
Last Posted Date
2022-12-06
Lead Sponsor
Centre Leon Berard
Target Recruit Count
80
Registration Number
NCT03472716
Locations
🇫🇷

Centre Léon Bérard, Lyon, France

Efficacy of Cryotherapy Combined or Not With Analgesics in Uncontrolled Painful Musculoskeletal Metastasis

First Posted Date
2018-02-22
Last Posted Date
2021-10-19
Lead Sponsor
Centre Leon Berard
Target Recruit Count
18
Registration Number
NCT03441139
Locations
🇫🇷

Centre Léon Bérard, Lyon, France

🇫🇷

Institut Bergonié, Bordeaux, France

🇫🇷

Institut de Cancérologie de Montpellier-Val d'Aurelle, Montpellier, France

and more 5 locations

Trial Evaluating Hypnosis Using Virtural Reality vs Standard Pain Management During Musculoskelettal Biopsy

First Posted Date
2018-02-01
Last Posted Date
2018-08-23
Lead Sponsor
Centre Leon Berard
Target Recruit Count
99
Registration Number
NCT03418597
Locations
🇫🇷

Centre Leon Berard, Lyon, France

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2018-01-24
Last Posted Date
2021-10-22
Lead Sponsor
Centre Leon Berard
Target Recruit Count
1
Registration Number
NCT03408652
Locations
🇫🇷

Centre Leon Berard, Lyon, France

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Not Applicable
Active, not recruiting
Conditions
Interventions
First Posted Date
2017-12-18
Last Posted Date
2024-08-26
Lead Sponsor
Centre Leon Berard
Target Recruit Count
376
Registration Number
NCT03375437
Locations
🇫🇷

Centre Georges-Francois Leclerc, Dijon, France

🇫🇷

Centre Antoine Lacassagne, Nice, France

🇫🇷

Centre Léon Bérard, Lyon, France

and more 7 locations

Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6

First Posted Date
2017-11-29
Last Posted Date
2023-02-23
Lead Sponsor
Centre Leon Berard
Target Recruit Count
25
Registration Number
NCT03356223
Locations
🇫🇷

Centre Léon Bérard, Lyon, France

🇫🇷

Hôpital Saint-André, Bordeaux, France

🇫🇷

Centre Antoine Lassagne, Nice, France

© Copyright 2024. All Rights Reserved by MedPath